MNTKMontauk Renewables, Inc.

$2.13-3.8% 1Y

$2.13

$1.1252 weeks$2.95

Is the price fair?

Good

Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Vs its own P/E rangecheaper than 76% of its own historyderived

Cheap vs its own history: P/E 35.4 vs a 57.5 median over 17 quarters (−38% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What MNTK's price assumes

Montauk Renewables, Inc. trades at 35.4× earnings against 31.1× for the median Specialty Chemicals name, more expensive than its own group.

35.4

Trailing P/E · Specialty Chemicals median 31.1 · 1.14× the median: the market pays up for this one

Price / sales: 1.18
Price / sales · as of 2026-Q2
Price / book: 0.84
Price / book · as of 2026-Q2
EV / sales: 1.89
EV / sales

Details›

Price / bookas of 2026-Q2: 0.84
EV / EBIToperating margin 0.59%: the multiple describes the denominator: not meaningful
EV / salesas of 2026-Q2: 1.89
Basic Materials median P/E202 names: 20.6
Specialty Chemicals median P/E43 names: 31.1
Market capitalisation142.3 million shares, counted Jul 31, 2026: $302M

What the market has paid for these earnings: 17 quarters of its own multiple × $0.06 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$2.51
Its own P/E history, median	$3.45
Its own P/E history, upper quartile	$4.55
52-week range	$1.12 – $2.95
Today	$2.13

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.